Clinical trial · Observational
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
NCT02961296CI-TRIAL-00024771unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to make nationwide registry for antimicrobial resistance of Helicobacter pylori using single method with agar dilution in Korea.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Gastritis | — | UNRESOLVED | — |
| Helicobacter Pylori Infection | — | UNRESOLVED | — |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Peptic Ulcer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The rate of exceeding the resistance criteria in Helicobacter pylori(H. pylori) antibiotic susceptibility test(Agar dilution method)
- timeFrame
- 6 more days
- description
- The resistance criterion specifies that Clarithromycin is excess of 1.0 μg/mL, Amoxicillin is excess of 0.5 μg/mL, Metronidazole is excess of 8 μg/mL, Tetracycline is excess of 4 μg/mL, Levofloxacin is excess of 1 μg/mL and Ciprofloxacin is excess of 1 μg/mL. All of resistance criteria follow a criteria of NCCLS(National Committee for Clinical Laboratory Standards)
Secondary outcomes (2)
- measure
- The gap of the rate of the antibiotic resistance to H. pylori by regional groups
- timeFrame
- 6 more days
- measure
- The success rate of H. pylori strain separation
- timeFrame
- 6 more days
- description
- Analyze the case of inseparable H. pylori strain and the reason of failure for culture after H. pylori strain separation.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 79 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 19 to 79 year person who need the examination of Helicobacter pylori infection during upper gastrointestinal endoscopy. * No history of Helicobacter pylori eradication. * No history of antibiotics within one month. * Person who agree on the consent. Exclusion Criteria: * History of antibiotics more than 3 days sequentially within one month. * History of subtotal gastrectomy. * Person who does not agree on the consent.
References
Publications (0)
Data not yet available
No reference posted for this study.